| Applications and limitations of dendrimers in biomedicine AA Chis, C Dobrea, C Morgovan, AM Arseniu, LL Rus, A Butuca, ... Molecules 25 (17), 3982, 2020 | 288 | 2020 |
| Microbial resistance to antibiotics and effective antibiotherapy AA Chiș, LL Rus, C Morgovan, AM Arseniu, A Frum, AL Vonica-Țincu, ... Biomedicines 10 (5), 1121, 2022 | 33 | 2022 |
| The particularities of pharmaceutical care in improving public health service during the COVID-19 pandemic S Ghibu, AM Juncan, LL Rus, A Frum, CM Dobrea, AA Chiş, FG Gligor, ... International journal of environmental research and public health 18 (18), 9776, 2021 | 29 | 2021 |
| Identification and quantification of phenolic compounds from red grape pomace A Frum, C Georgescu, FG Gligor, E Lengyel, DI Stegarus, CM Dobrea, ... Scientific Study & Research. Chemistry & Chemical Engineering, Biotechnology …, 2018 | 15 | 2018 |
| Determination of a Mixture of Plantago lanceolata L. and Salvia officinalis L. by High-Performance Liquid Chromatography with Ultraviolet Detection (HPLC-UV) FG Gligor, A Frum, LG Vicaș, M Totan, C Roman-Filip, CM Dobrea Analytical Letters 53 (9), 1391-1406, 2020 | 14 | 2020 |
| Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy AA Chis, CM Dobrea, LL Rus, A Frum, C Morgovan, A Butuca, M Totan, ... Molecules 26 (19), 5976, 2021 | 13 | 2021 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing A Frum, CM Dobrea, LL Rus, LI Virchea, C Morgovan, AA Chis, ... Nutrients 14 (15), 3065, 2022 | 10 | 2022 |
| Biopolymeric prodrug systems as potential antineoplastic therapy AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... Pharmaceutics 14 (9), 1773, 2022 | 7 | 2022 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing. Nutrients. 2022; 14: 3065 A Frum, CM Dobrea, LL Rus, L Virchea, C Morgovan, AA Chis, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published, 2022 | 5 | 2022 |
| Some Brassicaceae Extracts as Potential Antioxidants and Green Corrosion Inhibitors IMC Ienașcu, A Căta, AA Chis, MN Ştefănuț, P Sfîrloagă, G Rusu, ... Materials 16 (8), 2967, 2023 | 4 | 2023 |
| A Descriptive Analysis of Direct Oral Anticoagulant Drugs dosing errors based on spontaneous reports from the EudraVigilance database C Morgovan, CM Dobrea, AA Chis, AM Juncan, AM Arseniu, LL Rus, ... Pharmaceuticals 16 (3), 455, 2023 | 4 | 2023 |
| SILYMARIN FOOD SUPPLEMENTS-ORAL SOLID DOSAGE FORMS FG Gligor, CM Dobrea, C Georgescu, LAV Gligor, A Frum, M Totan Scientific Study & Research. Chemistry & Chemical Engineering, Biotechnology …, 2016 | 4 | 2016 |
| A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection BI Vintila, AM Arseniu, C Morgovan, A Butuca, V Bîrluțiu, CM Dobrea, ... Antibiotics 13 (2), 144, 2024 | 3 | 2024 |
| Comparative antioxidant and antimicrobial activities of several conifer needles and bark extracts DI Popescu, A Frum, CM Dobrea, R Cristea, FG Gligor, LG Vicas, ... Pharmaceutics 16 (1), 52, 2023 | 3 | 2023 |
| Determination of Zn2+ in Solid Pharmaceutical Dosage Forms by Means of Spectrophotometry in Micellar Media: Method Validation LL Rus, AM Juncan, VI Crăciun, A Frum, SC Hegheș, A Butuca, ... Applied Sciences 12 (9), 4476, 2022 | 3 | 2022 |
| Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets AA Chiş, I Crăciun, CM Dobrea, FG Gligor, A Bărbat, LL Rus Romanian Journal of PHARMACEUTICAL PRACTICE| Vol. XIII 54 (4), 2020 | 2 | 2020 |
| Liquiritiae radix and possible substituents—comparative LC/MS analysis of specific flavonoids C Dobrea AMT 21 (4), 111-113, 2016 | 2 | 2016 |
| Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics 2022, 14, 1773 AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database A Butuca, CM Dobrea, AM Arseniu, A Frum, AA Chis, LL Rus, S Ghibu, ... Biomedicines 12 (5), 1124, 2024 | | 2024 |
| Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance C Morgovan, CM Dobrea, A Butuca, AM Arseniu, A Frum, LL Rus, AA Chis, ... Biomedicines 12 (5), 953, 2024 | | 2024 |
